Latest: Q3 2026 · from the cash-flow statements filed with the SEC
Free cash flow−$11.5M in Q3 2026 · $7.4M over twelve months
Operating cash flow$4.4M
Capital spending−$16.0M
Free cash flow−$11.5M
Cash conversion cycle45 days
Analysis
In Q3 2026, iRhythm Holdings generated $4.4M of operating cash flow and spent $16.0M on capital projects, leaving free cash flow of −$11.5M. That is $31.6M less than in Q3 2025 ($20.1M).
Over the twelve months to Sep 30, 2026, operating cash flow was $55.6M; the largest uses were capital spending ($48.2M), other financing ($3K); besides operations, cash came from other investing ($134M), shares issued ($7.6M); the cash balance rose by $149M.
Operating cash flow was $4.4M against net income of −$29.9M. The largest differences: receivables −$23.5M, stock-based pay +$19.5M, payables +$7.9M.
Its cash conversion cycle was 45 days (receivables 34 + inventory 37 − payables 26).
Free cash flow
Operating cash flow less capital spending.Latest (Q3 2026): Operating cash flow $4.4M, Capital spending $16.0M.
Capital allocation, year by year
Over these 5 years operating cash flow totalled −$26.6M; the largest uses were capital spending ($179M) and operating cash flow ($111M). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$561M
Debtnone
Net cash$561M
iRhythm Holdings funds itself: free cash flow was $7.4M over the last twelve months, with $561M of cash and investments and no debt on the balance sheet.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Quarter
Receivable days
Inventory days
Payable days
Cash conversion cycle
Q3 2026
34
37
26
45
Q2 2026
34
35
19
49
Q1 2026
35
35
8
62
Q4 2025
33
31
8
57
Q3 2025
38
31
17
52
Q2 2025
40
28
21
46
Q1 2025
46
26
17
54
Q4 2024
44
27
14
57
Every quarter
Quarter
Operating cash flow
Capital spending
Shares issued
Cash drawn (+) / kept (−)
Free cash flow
Q3 2026
$4.4M
−$16.0M
$403K
−$158M
−$11.5M
Q2 2026
$51.1M
−$13.6M
$4.1M
−$6.5M
$37.5M
Q1 2026
−$26.2M
−$6.9M
$149K
−$4.1M
−$33.1M
Q4 2025
$26.2M
−$11.7M
$3.0M
$19.6M
$14.5M
Q3 2025
$34.9M
−$14.8M
$825K
$53.5M
$20.1M
Q2 2025
$27.7M
−$10.4M
$7.1M
$66.2M
$17.3M
Q1 2025
−$7.9M
−$9.4M
$1.7M
$44.3M
−$17.3M
Q4 2024
$19.2M
−$6.8M
$3.0M
$99.9M
$12.4M
iRhythm Holdings: income statement and cash flow
iRhythm Holdings, Q3 2026: revenue $222M (+15% year over year), operating margin -14.7%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.